PSYBF Stock Price, Chart, Stats & News

PsyBio Therapeutics Corp
Save
PsyBio Therapeutics Corp (PSYBF) does not currently pay a dividend.
1,275
Market cap
–
Current P/E
–
Forward P/E
PSYBF chart
About
Health care
Sector
Biotechnology
Industry
PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders.
Similar securities
Based on sector and market capitalization
Report issue





